The Biotech Growth Trust PLC (“the Company”)
Compliance with Market Abuse Regulation
20 April 2020
The Company confirms that:
a) all inside information which the Directors and Company may
have had has been notified to a Regulated Information Service (“RIS”);
b) the Company’s net asset value per share is calculated and
announced through a RIS on a daily basis;
c) the Company has no reason to believe that there will be any
material difference between the net asset value per share as at close of
business on Tuesday 31 March 2020, which was announced on Wednesday, 1 April
2020, and the financial information to be published in the announcement of its
results for the year ended 31 March 2020.
The Company is, therefore, not prohibited from dealing in its own securities
during the closed period, as defined by the EU Market Abuse Regulation, which
will end on the date of the publication of its results for the year ended 31
March 2020, expected to be on or after Thursday, 21 May 2020.
-ENDS-
For further information please contact:
Mark Pope Frostrow Capital LLP - 020 3 008 4913
Copyright (c) 2020 PR Newswire Association,LLC. All Rights Reserved